Clinical Trial Supplies Market Analysis Report 2025-2029: Breakdown by Manufacturing, Sourcing, Packaging, Labelling, Logistics, Small Molecules, Biologics, Vaccines [Yahoo! Finance]
ArcBest Corporation (ARCB)
Last arcbest corporation earnings: 1/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
arcb.com/investor-relations
Company Research
Source: Yahoo! Finance
Key trends include a shift to decentralized trials, advanced logistics, and digitalization, involving IoT and AI for enhanced supply chain management. Dominating segments include Logistics & Distribution Services and Phase III trials, with North America leading the market. Major stakeholders include pharmaceutical companies and CROs, leveraging technology for improved efficiency. Key players: Almac Group, Thermo Fisher, and PCI Pharma Services. Clinical Trial Supplies Market Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- "Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The global Clinical Trial Supplies market is poised to reach USD 8.18 billion by 2030 from USD 5.34 billion in 2025, exhibiting a CAGR of 8.9% The report offe
Show less
Read more
Impact Snapshot
Event Time:
ARCB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARCB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARCB alerts
High impacting ArcBest Corporation news events
Weekly update
A roundup of the hottest topics
ARCB
News
- ArcBest (NASDAQ:ARCB) had its price target raised by analysts at Stifel Nicolaus from $73.00 to $85.00. They now have a "buy" rating on the stock.MarketBeat
- ArcBest: Stay Bullish That ARCB Can Hit Its EPS Guide [Seeking Alpha]Seeking Alpha
- ArcBest (NASDAQ:ARCB) had its price target lowered by analysts at Citigroup Inc. from $87.00 to $83.00. They now have a "buy" rating on the stock.MarketBeat
- ArcBest (NASDAQ:ARCB) had its price target lowered by analysts at Bank of America Corporation from $73.00 to $72.00. They now have a "neutral" rating on the stock.MarketBeat
- ArcBest stems revenue declines in November, margin hurdles remain [Yahoo! Finance]Yahoo! Finance
ARCB
Earnings
- 11/5/25 - Miss
ARCB
Sec Filings
- 12/9/25 - Form 4
- 12/1/25 - Form 8-K
- 11/26/25 - Form 8-K
- ARCB's page on the SEC website